Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Research ArticlePractice

Answer: Can you identify this condition?

Claudio Guarneri and Giancarlo Valenti
Canadian Family Physician December 2008; 54 (12) 1698;
Claudio Guarneri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giancarlo Valenti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Answer to Dermacase continued from page 1697

4. Amelanotic subungual melanoma

Acral lentiginous melanoma is the most common form of cutaneous melanoma in dark-skinned persons; however, it occurs infrequently among whites.1 It can involve the palms, soles, or nail beds of the hands and feet. When it involves the nail bed it is referred to as subungual melanoma (SM).

Subungual melanoma is rare and accounts for only 1% to 3% of all cases of melanoma. In reviews of SM, the median age of affected patients is 59 years, with a slight increase in prevalence among men. The lesions are predominantly located on the hands (55%) as opposed to feet, and the thumb and big toe are most frequently involved. Subungual melanoma is usually asymptomatic and manifests with partial or total onycholysis and erosion and ulceration of the nail bed.2 It can start at any time after puberty and affects only a single digit; some authors also underline the importance of preceding trauma as a triggering factor for malignant transformation, as its occurrence is more than coincidental in such cases.3 Often, an important clue to the diagnosis of SM is the Hutchinson sign, which is characterized by the extension of brown-black pigment from the nail bed, matrix, and nail plate onto the adjacent cuticle and proximal or lateral nail folds.2,4

Unlike classical skin melanomas, which clinically present with a wide variety of colour ranging from black to black-blue to shades of brown and pink all within the same lesion area, amelanotic melanoma shows little or no pigmentation upon visual inspection. Although any clinical subtype of melanoma can be amelanotic and the incidence of amelanotic melanoma in all malignant melanoma is low (2% to 8% of cases), the subungual region seems to be an area of predilection—25% of SMs are amelanotic.5

Diagnosis

Subungual melanoma is an insidious, frequently mis-diagnosed condition because of its nonspecific clinical features, and lack of pigmentation adds further difficulty to an already puzzling diagnosis. Patients and physicians must be educated to recognize the clinical signs of this particular melanoma; in dermatologic consultation, the skilled eye of a specialized observer, along with dermoscopy (the new method for noninvasive diagnosis of melanoma), is the best instrument in the selection of lesions for excisional biopsy. Precise biopsies are strongly recommended, even in lesion sites that are not easily accessible, such as the nail apparatus. Radiographic studies of the affected area are useful to exclude the possibility of bone lesions.2,6,7

Differential diagnoses include a variety of benign and malignant conditions, such as chronic paronychia, onychomycosis, subungual hematoma, pyogenic granuloma, glomus tumour, subungual verruca, mucous cyst, sub-ungual fibroma, keratoacanthoma, carcinoma of the nail bed, and subungual exostosis.

With regard to prognosis, the outlook of SM is generally comparable with that of the other melanomas. The Breslow thickness remains the single most important prognostic factor, and there is no evidence to suggest that amelanotic melanocytes behave more aggressively than their pigmented counterparts.

Treatment

The prognosis of malignant SM is poor because most lesions are at an advanced stage at the time of diagnosis (mean Breslow thickness 4.8 mm). As in all types of melanoma, there is a direct relationship between increasing tumour thickness and decreasing survival time: a 5-year survival period is estimated for 88% of patients with a Breslow thickness of > 2.5 mm, as opposed to 40% for those with a Breslow thickness of ≤ 2.5 mm. Ulceration and bone involvement are also unfavourable prognostic factors.6–8

Given the rarity of SM and the general lack of experience in its treatment, patients would benefit from being managed by multidisciplinary teams in designated skin cancer centres at the earliest possible stage. Treatment remains surgical and consists of complete excision of the tumour. The level of amputation has been debated; however, as long as clear margins are obtained, conservative levels of amputation are safe and do not adversely affect overall survival with good residual function capacity.

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    RidgewayCAHiekenTJRonanSGDas GuptaTKAcral lentiginous melanomaArch Surg199513018892
    OpenUrlCrossRefPubMed
  2. ↵
    FinleyRK3rdDriscollDLBlumensonLEKarakousisCPSubungual melanoma: an eighteen-year reviewSurgery1994116196100
    OpenUrlPubMed
  3. ↵
    O’TooleEAStephensRYoungMMTannerABarnesLSubungual melanoma: a relation to direct injury?J Am Acad Dermatol19953335258
    OpenUrlPubMed
  4. ↵
    BaranRKechijianPHutchinson’s sign: a reappraisalJ Am Acad Dermatol19963418790
    OpenUrlCrossRefPubMed
  5. ↵
    KochSELangeJRAmelanotic melanoma: the great masqueraderJ Am Acad Dermatol2000425 Pt 17314
    OpenUrlCrossRefPubMed
  6. ↵
    BanfieldCCRedburnJCDawberRPThe incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regionsBr J Dermatol199813922769
    OpenUrlCrossRefPubMed
  7. ↵
    KatoTSuetakeTSugiyamaYTabataNTagamiHEpidemiology and prognosis of subungual melanoma in 34 Japanese patientsBr J Dermatol199613433837
    OpenUrlCrossRefPubMed
  8. ↵
    HeatonKMel-NaggarAEnsignLGRossMIBalchCMSurgical management and prognostic factors in patients with subungual melanomaAnn Surg19942192197204
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 54 (12)
Canadian Family Physician
Vol. 54, Issue 12
1 Dec 2008
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Answer: Can you identify this condition?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Answer: Can you identify this condition?
Claudio Guarneri, Giancarlo Valenti
Canadian Family Physician Dec 2008, 54 (12) 1698;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Answer: Can you identify this condition?
Claudio Guarneri, Giancarlo Valenti
Canadian Family Physician Dec 2008, 54 (12) 1698;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • 4. Amelanotic subungual melanoma
    • Diagnosis
    • Treatment
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • Question: Can you identify this condition?
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
  • Managing type 2 diabetes in primary care during COVID-19
Show more Practice

Dermacase

  • Question: Can you identify this condition?
  • Answer: Can you identify this condition?
  • Question: Can you identify this condition?
Show more Dermacase

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire